RxDoctor Payments Data

Valay Parikh

Clinical Cardiac Electrophysiology · Staten Island, NYNPI 1447480959

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (30.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Abbott accounts for 65.2% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $14,143, 2.8 times the $5,049 reported in 2019.

$48,640in general payments, 2019–2025

Across 236 payments — averaging $206.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$32K
  • Medtronic$12K
  • Philips North America LLC$2K
  • Cvrx, Inc.$1K
  • Boston Scientific$835
  • Edwards Lifesciences$154
  • plus $621 from 6 others
$616,244in research payments, 2019–2025

Across 64 payments — averaging $9628.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Adagio Medical, Inc.$560K
  • Abbott$56K

What the payments were for

  • Consulting fees$13,07127%
  • Speaking & faculty fees$14,72530%
  • Travel & lodging$14,19029%
  • Food & beverage$6,55713%
  • Education$970%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,640 in reported general payments places this provider in the 75th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York

Medicare billing

Part B allowed, 2024
$490,859
Medicare patients
822
Services billed
5,203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban79$93,962
XareltoRivaroxaban11$13,442
Amiodarone Hcl65$998
Metoprolol Succinate46$538
Flecainide Acetate15$462
Losartan Potassium11$68
Metoprolol Tartrate20$51

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Staten Island

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →